Phase 3 clinical trial has been given approval by FDA
The FDA has given Ocugen permission to start their phase 3 gene therapy clinical trial for retinitis pigmentosa (RP).
Search
Search results
e-Newsletter May 2024
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Research news round-up – Spring 2024
A round-up of the latest research into inherited retinal conditions - February 2024.
Taking part in the 2021 Virtual London Marathon
Caryn talks about her experience taking part in the 2021 Virtual London Marathon.
2024 TCS London Marathon
Join #TeamRetinaUK for the iconic 2024 TCS London Marathon! Soak up the incredible atmosphere as you run from Blackheath to The Mall finish line where you’ll get your very own marathon medal.
Hope for the future
In this article, we hear Colin's story and the reasons why he has hope for the future.
Royal Parks Half Marathon
This stunning central London half marathon, takes in some of the capital’s world-famous landmarks on closed roads.